Asensus Surgical Archives - Page 2 of 4

Asensus secures pediatric indication for its robotic surgery system

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical announced today that FDA has cleared an expanded pediatric indication for its Senhance robotic surgery system.

Research Triangle Park, North Carolina–based Asensus says Senhance is the first and only digital laparoscopic surgery solution for pediatric patients. During the company’s fourth-quarter earnings announcement early this month, it said it expected the pediatric indication this year.

The Senhance system’s Intelligent Surgical Unit combines 3 mm instrumentation, a 5 mm camera scope, haptic feedback, and advanced clinical intelligence, according to Asensus.

Asensus’ Senhance system also has regulatory approval for pediatric patients in the EU and Japan. The company reports strong early clinical utilization in Europe. Surgeons in Europe have performed pediatric general, upper GI, colorectal, and urologic procedu…

Asensus Surgical expects FDA clearance for surgical robot in pediatric use this year

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) shares dipped today on fourth-quarter results that came in mixed compared to the consensus forecast.

The company provided an outlook for the year ahead that includes the expected clearance of a regulatory hurdle, though.

Shares of ASXC fell 2.6% to 67¢ apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.8%.

The Research Triangle Park, North Carolina-based surgical robot maker posted losses of $17.9 million. That amounts to losses of 8¢ per share on sales of $2.5 million for the three months ended Dec. 31, 2022.

Asensus’ bottom line slipped deeper into the red by about $2 million. Sales came in 0.4% behind the same period one year ago.

Adjusted to exclude one-time items, earnings per share…

Asensus Surgical unveils next-gen Luna surgical robot platform

The Luna platform. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it introduced a next-generation surgical robot platform called “Luna.”

Research Triangle Park, North Carolina-based Asensus designed luna as an integrated digital surgery solution. It features a next-generation surgical platform and instruments, plus real-time intraoperative clinical intelligence. Its final component, a secure cloud platform, applies machine learning to deliver clinical insights.

Altogether, the Luna platform enables Asensus’ vision of performance-guided surgery, according to a news release.

The company’s unveiling comes on the heels of two major steps contributing to its progress in surgical robotics. Last week, the company announced a collaboration with Google Cloud on the machine learning aspect of its platform. Two days later, the company announced plans to work with Karl Storz on the marketing and development…

Asensus, Karl Storz partner on surgical robot marketing, development

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into a memorandum of understanding with Karl Storz VentureONE.

Karl Storz VentureOne is a wholly-owned subsidiary of Karl Storz SE, a maker of endoscopes and other medical instruments and devices. The family-owned company closely collaborates with surgeons and healthcare partners around the globe on technologies for minimally invasive procedures.

The agreement between the surgical robot maker and Karl Storz includes plans for marketing and development. Research Triangle Park, North Carolina-based Asensus develops the Senhance surgical robot platform. It also develops the Intelligent Surgical Unit (ISU) for Senhance.

Asensus designed ISU as a real-time intraoperative surgical image analytics platform. It leverages augmented intelligence to help reduce surgical variability. Earlier this week,…

Asensus Surgical to collaborate with Google Cloud on machine learning for surgical robots

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into a multi-year collaboration with Google Cloud.

The collaboration integrates Google Cloud’s secure cloud data architecture and machine learning into the Asensus surgical robot platform. It further expands the capabilities of Asensus’ performance-guided surgery framework through its Intelligent Surgical Unit (ISU).

Research Triangle Park, North Carolina–based Asensus designed its performance-guided surgery to enhance accuracy and efficiency. The company says its platform can help surgeons avoid complications and improve patient outcomes.

“We are thrilled to be collaborating with Google Cloud to realize and scale our Performance Guidance Surgery capabilities, by leveraging the data collected by our state-of-the-art ISU technology in conjunction with Google Cloud’s leading machi…

Asensus Surgical wins CE mark approval for expanded machine learning

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it received CE mark for an expansion of machine vision capabilities with its surgical robot.

The approval expands machine vision for the previously cleared Intelligent Surgical Unit (ISU) of the Senhance system. This regulatory nod makes the expanded ISU capabilities available across Europe, Japan and the U.S. The FDA cleared the machine vision capabilities in September 2021.

According to a news release, the approval also makes Senhance one of the first surgical robot systems approved through EU MDR.

“We are thrilled to be able to offer these ground-breaking ISU capabilities to surgeons in the EU,” said Asensus President and CEO Anthony Fernando. “Surgeon feedback from the expanded feature set across the U.S. and Japan has been tremendous, and we look forward to partnering with new and exi…

Asensus Surgical projects at least $2.2M in Q4 sales

[Image from Asensus Surgical]Asensus Surgical (NYSE:ASXC) this week announced preliminary fourth-quarter results that came up well short of Wall Street estimates.

The company expects to report revenues between $2.2 million and $2.8 million. Analysts expected the company to bring in approximately $3.7 million over the three months ended Dec. 31, 2022.

Asensus expects its full-year revenue to total between $6.8 million and $7.4 million.

During the fourth quarter, the company reported 23% growth in procedures with its Senhance surgical robot. It initiated five Senhance programs during the quarter, including multiple in Japan. The company’s 2,650 procedures performed globally in 2022 tops 2021 totals by 26%.

Shares of ASXC have been rising since the reporting of these preliminary figures. The day of the report, Jan. 9, shares closed trading at 45¢ apiece. Today, they’re up to approximately 60¢ each.

“We are very pleased with what…

Asensus Surgical announces another surgical robot placement in Japan

[Image from Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into a lease agreement with a Japanese hospital for its Senhance surgical robot.

Research Triangle Park, North Carolina-based Asensus entered the agreement with Kitakyushu General Hospital. It marks the second Senhance system leased at the hospital in the Kyushu area of Japan. Asensus placed the first one in Japan in January 2020. Kitakyushu is the first hospital to install multiple Senhance surgical robots and it completed more than 300 procedures with the system to date.

Asensus continues to expand its reach in Japan following last week’s Senhance placement in Kashiwa. Additionally, In September, Saiseikai Shiga Hospital in Ritto, Japan, agreed to lease a surgical robot.

“We are very excited to see one of our first Japanese placements expanding their Senhance program to include a second system,” said Anthony Fernando, Asensus Surgical President and CEO. “This m…

Asensus Surgical announces Senhance surgical robot placement in Japan

[Image from Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into an agreement to lease a Senhance surgical robot to a Japanese hospital.

Kashiwa Kosei General Hospital (Kashiwa, Japan) agreed to lease the surgical robot system. It marks the second recent adoption of Senhance in Japan. In September, Saiseikai Shiga Hospital in Ritto, Japan, agreed to lease a surgical robot.

“We are pleased to be partnering with another impressive institution as we continue to see high adoption rates in one of the fastest growing regions for Asensus,” said Anthony Fernando, Asensus Surgical president and CEO. “The recently approved thoracic indication will be a great addition to the Kashiwa Kosei General Hospital’s surgery department.”

Senhance, a first-of-its-kind digital laparoscopic surgical robot, uses augmented intelligence to perform procedures through machine learning. It features surgical assurance through haptic feedback, eye-track…

Japanese Hospital to initiate program with Asensus Surgical’s Senhance surgical robot

[Image from Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that a hospital in Japan agreed to lease and utilize its Senhance surgical robot system.

Saiseikai Shiga Hospital in Ritto, Japan, agreed to a deal with Research Triangle Park, North Carolina-based Asensus.

The hospital will use the Asensus Senhance surgical system. The first-of-its-kind digital laparoscopic surgical robot uses augmented intelligence to perform procedures through machine learning. It features surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization.

Asensus said in a news release that Senhance is the first platform to offer 3mm instruments. They are the smallest instrument available in the world on a robotic surgical platform.

“We are very excited to be partnering with Saiseikai Shiga Hospital, one of the leading hospitals in Japan. While the system will be initially utilized in the General Surgery Department, we look forwar…

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …

Asensus Surgical says procedures up by more than a third in Q2

Asensus Surgical (NYSE American: ASXC) today announced mixed Q2 results that also included 34% procedures growth year-over-year.

The Research Triangle Park, North Carolina–based surgical robotics and digital surgery company lost $19.6 million, or 8¢ per share, off $994,000 in revenue for the quarter ended June 20, 2022 — versus a loss of $13.2 million, or 6¢ per share, off $1.1 million in revenue for the same quarter a year ago.

Wall Street analysts had expected EPS of –8¢ on $1.25 million in revenue.

During Q2, Asensus announced the installation of a Senhance system at the University Hospital Tübingen in Germany. The company also has two additional orders that have not yet been installed — including one heading toward one of the countries in the Commonwealth of Independent States, the international organization that includes Russia and many other former republics of the Soviet Union.

The company is seeking to expand the use of its Intelligent Sur…